The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
The Crisis in Antibiotic Resistance
Abstract
The synthesis of large numbers of antibiotics over the past three decades has caused complacency about the threat of bacterial resistance. Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of the exchange of genetic material via plasmids and transposons. Streptococcus pneumoniae, Streptococcus pyogenes, and staphylococci, organisms that cause respiratory and cutaneous infections, and members of the Enterobacteriaceae and Pseudomonas families, organisms that cause diarrhea, urinary infection, and sepsis, are now resistant to virtually all of the older antibiotics. The extensive use of antibiotics in the community and hospitals has fueled this crisis. Mechanisms such as antibiotic control programs, better hygiene, and synthesis of agents with improved antimicrobial activity need to be adopted in order to limit bacterial resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overuse and antibiotic resistance have proliferated[422]”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [422]
Citations
Cites
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,887
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 887
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 804
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 776
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 704
Bugg, T. D. H., Wright, G. D., Dutka‐Malen, S., Arthur, M., Courvalin, P. M., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 642
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 629
McMurry, L. M., Petrucci, R., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 606
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mr.51.1.88-134.1987 · Cited by 593
Research works printed but not linked: 30
- AMERICAN JOURNAL OF MEDICINE 91 3B (1991).
- APPELBAUM, P. C., EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 367 (1987).
- BANERJEE, S.N., SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989, AMERICAN JOURNAL OF MEDICINE 91: S86 (1991).
- BOYCE, J. M., JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 249: 2803 (1983). · DOI
- Bryan, L. E., Antimicrobial Drug Resistance 241 (1984).
- BUOHO, A. Y., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 B: 41 (1988).
- BUSH, K, ANTIMICROB AGENTS CH 33: 339 (1989).
- COOKSON, B. D., JOURNAL OF APPLIED BACTERIOLOGY 69: 55S (1990).
- DEGUCHI, K, JAPANESE JOURNAL OF ANTIBIOTICS 42: 2133 (1990).
- Fisher, M., New Antibacterial Strategies 177 (1990).
- Higgins, C. F., New Antibacterial Strategies 193 (1990).
- KHARDORI, N, REVIEWS OF INFECTIOUS DISEASES 12: 996 (1990).
- LUJAN, R, REVISTA ESPANOLA DE QUIMIOTERAPIA 3: 323 (1990).
- McMurry, L., Proceedings of the National Academy of Sciences of the United States of America 77: 3974 (1980).
- MILATOVIC, D, EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 234 (1987).
- Mitsuhashi, S., The Aminoglycosides 97 (1982).
- MOELLERING, R, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 28: 1 (1991).
- MUDDER, R.R., ARCH INTERN MED 147: 1672 (1987). · DOI
- NEU, H. C., AMERICAN JOURNAL OF MEDICINE 76: 11 (1984).
- NEU, H.C., AMERICAN JOURNAL OF MEDICINE 7 5A: 2 (1985).
- Neu, H. C., Human Pharmacology 613 (1991).
- Normark, S., New Antibacterial Strategies 161 (1990).
- PHILLIPS, I, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 27: 40 (1991).
- SCHABERG, D. R., AMERICAN JOURNAL OF MEDICINE 91 3B: 725 (1991).
- SKURRAY, R. A., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 21 C: 19 (1988).
- SLOCOMBE, B,JOURNAL OF HOSPITAL INFECTION 19: 19 (1991).
- SMITH, A, INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 5: 177 (1992).
- TALLY, F. P., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 A: 63 (1989).
- TENOVER, F. C., AMERICAN JOURNAL OF MEDICINE 91: S76 (1991).
- UTTLEY, AHC, VANCOMYCIN-RESISTANT ENTEROCOCCI, LANCET 1: 57 (1988).
Cited by
Sorted by citations
Items 401–500 of 1,000
Bogialli, S., Curini, R., Corcia, A. D., Nazzari, M., & Samperi, R. (2003) · Analytical Chemistry · doi:10.1021/ac0262816 · Cited by 110
A Multidrug Resistance Regulatory Chromosomal Locus Is Widespread among Enteric Bacteria
Cohen, S., Yan, W., & Levy, S. B. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.2.484 · Cited by 110
“Bacterial resistance to multiple antibiotics has emerged as a leading cause of treatment failure [1, 2].”
BackgroundTailored Silica–Antibiotic Nanoparticles: Overcoming Bacterial Resistance with Low Cytotoxicity
Capeletti, L. B., de Oliveira, L. F., Gonçalves, K. D. A., de Oliveira, J. F. A., Saito, Â., Kobarg, J., dos Santos, J. H. Z., & Cardoso, M. B. (2014) · Langmuir · doi:10.1021/la4046435 · Cited by 109
Lovering, A. L., Gretes, M. C., Safadi, S. S., Danel, F., de Castro, L., Page, M. G. P., & Strynadka, N. C. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355644 · Cited by 109
Porphyrin‐based, light‐activated antimicrobial materials
Bozja, J., Sherrill, J., Michielsen, S., & Stojiljković, I. (2003) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.10773 · Cited by 109
Daigle, D. M., Hughes, D. W., & Wright, G. D. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80006-4 · Cited by 108
Purine sensing by riboswitches
Kim, J. N., & Breaker, R. R. (2007) · Biology of the Cell · doi:10.1042/bc20070088 · Cited by 117
“Bacteria have been rapidly gaining resistance to currently used antibiotics (Neu, 1992; Gold and Moellering, 1996), which means that developing novel antibiotics for new targets is crucial for fighting these antibiotic-resistant bacteria.”
BackgroundSaravanan, R., Li, X., Lim, K., Mohanram, H., Li, P., Mishra, B., Basu, A., Lee, J., Bhattacharjya, S., & Leong, S. S. J. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.25003 · Cited by 108
Stone, S. C., Gonzales, R., Maselli, J. H., & Lowenstein, S. R. (2000) · Annals of Emergency Medicine · doi:10.1067/mem.2000.109341 · Cited by 108
Tintino, S. R., Oliveira–Tintino, C. D. D. M., Campina, F. F., Silva, R. L. P., Costa, M. D. S., de Menezes, I. R. A., Júnior, J. T. C., Siqueira-Júnior, J. P., Coutinho, H. D. M., Leal‐Balbino, T. C., et al. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.04.003 · Cited by 107
Antibacterial properties and clinical potential of pleuromutilins
Goethe, O., Heuer, A. M., Ma, X., Wang, Z., & Herzon, S. B. (2018) · Natural Product Reports · doi:10.1039/c8np00042e · Cited by 107
Metzler, K., Hansen, G. M., Hedlin, P. D., Harding, E., Drlica, K., & Blondeau, J. M. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.02.021 · Cited by 107
“aureus resistance to ciprofloxacin readily occurred [1–3] and in some surveys of hospital-acquired infections, 90% or more of S.”
BackgroundBrandish, P. E., Burnham, M. K. R., Lonsdale, J. T., Southgate, R., Inukai, M., & Bugg, T. D. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7609 · Cited by 107
The Importance and Potential Uses of Olive Leaves
Erbay, Z., & İçıer, F. (2010) · Food Reviews International · doi:10.1080/87559129.2010.496021 · Cited by 107
“( 38 ) Furthermore, it was proved that olive leaves were especially effective against Klebsiella and Pseudomonas , two bacterial genera which pose major resistance problem( 39 ) and had antimicrobial effect against Escherichia coli and Candida albicans .”
BackgroundDo We Need to Put Society First? The Potential for Tragedy in Antimicrobial Resistance
Foster, K. R., & Grundmann, H. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030029 · Cited by 111
Antibacterial and anti-inflammatory agents that target endotoxin
Wyckoff, T. J. O., Raetz, C. R. H., & Jackman, J. E. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01230-x · Cited by 107
Ms, I., & Bruining, H. A. (2002) · The European Journal of Surgery · doi:10.1080/110241598750004210 · Cited by 107
Sun, X., Johnson, D. W., Caulder, D. L., Powers, R. E., Raymond, K. N., & Wong, E. H. (1999) · Angewandte Chemie · doi:10.1002/(sici)1521-3757(19990503)111:9 · Cited by 50
Gupta, A., Saleh, N. M., Das, R., Landis, R. F., Bigdeli, A., Motamedchaboki, K., Campos, A. R., Pomeroy, K., Mahmoudi, M., & Rotello, V. M. (2017) · Nano Futures · doi:10.1088/2399-1984/aa69fb · Cited by 107
The DAP pathway to lysine as a target for antimicrobial agents
Cox, R. J. (1996) · Natural Product Reports · doi:10.1039/np9961300029 · Cited by 106
The Desk encyclopedia of microbiology
(2004) · Choice Reviews Online · doi:10.5860/choice.42-1294 · Cited by 106
Upadhaya, S. D., & Kim, I. H. (2017) · Annals of Animal Science · doi:10.1515/aoas-2016-0079 · Cited by 105
Ceyhan, M., Yildirim, I. B., Ecevıt, Ç. Ö., Aydogan, A., Örnek, A., Salman, N., Somer, A., Hatipoğlu, N., Çamcıoğlu, Y., Alhan, E., et al. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.03.013 · Cited by 105
Fever in Pediatric Primary Care: Occurrence, Management, and Outcomes
Finkelstein, J. A., Christiansen, C. L., & Platt, R. G. (2000) · PEDIATRICS · doi:10.1542/peds.105.s2.260 · Cited by 105
Polyurethane coatings release bioactive antibodies to reduce bacterial adhesion
Rojas, I. A., Slunt, J. B., & Grainger, D. W. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00195-9 · Cited by 104
Fricke, W. F., Wright, M. S., Lindell, A. H., Harkins, D. M., Baker‐Austin, C., Ravel, J., & Stepanauskas, R. (2008) · Journal of Bacteriology · doi:10.1128/jb.00661-08 · Cited by 111
“Antibiotic resistance in bacterial pathogens is a major public health challenge worldwide, with increased morbidity and mortality due to bacterial infections and associated costs in billions of dollars in the United States alone (48, 57).”
BackgroundTam, V. H., Louie, A., Deziel, M. R., Liu, W., Leary, R. H., & Drusano, G. L. (2005) · The Journal of Infectious Diseases · doi:10.1086/430611 · Cited by 104
“achieved (which, in equation [2], includes both the EC50 and the H for the susceptible bacterial subpopulation and, in equation [3], includes both the EC50 and the H for the resistant bacterial subpopulation) NR, size of resistant bacterial subpopulation Ns, size of susceptible bacterial subpopulation POPmax, maximum…”
BackgroundVértesy, L., Ehlers, E., Kogler, H., Kurz, M. E., Meiwes, J., SEIBERT, G., VOGEL, M., & Hammann, P. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.816 · Cited by 104
Light as a Broad-Spectrum Antimicrobial
Gwynne, P. J., & Gallagher, M. P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00119 · Cited by 104
“…infection, resistance, phototherapy, photosensitizers, blue light, ultraviolet, infrared INTRODUCTION The rise of antibiotic resistance has been (Jawetz, 1963; Lyon and Skurray, 1987; Neu, 1992) and continues to be (Goff et al., 2017; Manaia, 2017; Schroeder et al., 2017) extensively reported.”
BackgroundAvailability of Antibiotics for Purchase Without a Prescription on the Internet
Mainous, A. G., Everett, C. J., Post, R. E., Díaz, V. A., & Hueston, W. J. (2009) · The Annals of Family Medicine · doi:10.1370/afm.999 · Cited by 106
β-Lactam synthetase: A new biosynthetic enzyme
Bachmann, B. O., Li, R., & Townsend, C. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9082 · Cited by 103
Infection after lung transplantation.
Paradis, I. L., & Williams, P. A. (1993) · PubMed · Cited by 103
Alhaji, N. B., & Isola, T. O. (2018) · One Health · doi:10.1016/j.onehlt.2018.11.001 · Cited by 102
“Massive use of antimicrobials is one of the most important factors promoting the emergence, selection, and dissemination of antimicrobial resistant pathogens in both veterinary and human medicine [12,13].”
BackgroundEffect of Lactobacillus casei as a Probiotic on Modulation of Giardiasis
Shukla, G., Devi, P., & Sehgal, R. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0197-3 · Cited by 102
“Moreover, due to the development of antibiotic resistance in pathogenic microorganisms [15] there is an urgent need for natural, biodegradable interventions that do not alter intestinal microflora.”
BackgroundMethicillin-resistant Staphylococcus aureus versus the burn patient
Cook, N. M. (1998) · Burns · doi:10.1016/s0305-4179(97)00114-9 · Cited by 102
RETRACTED: Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli
Ma, C., & Chang, G. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400137101 · Cited by 102
RetractedThe challenge of vancomycin-resistant enterococci: A clinical and epidemiologic study
Lam, S., Singer, C., Tucci, V., Morthland, V. H., Pfaller, M. A., & Isenberg, H. D. (1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90038-1 · Cited by 102
Dawane, B. S., Konda, S. G., Mandawad, G. G., & Shaikh, B. M. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.10.015 · Cited by 101
Trends in Photothermal Nanostructures for Antimicrobial Applications
Dediu, V., Ghițman, J., Pîrcălăbioru, G. G., Chan, K. H., Iliescu, F. S., & Iliescu, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119375 · Cited by 105
Goldstein, D. A., Tinland, B., Gilbertson, L. A., Staub, J. M., Bannon, G. A., Goodman, R. E., McCoy, R. L., & Silvanovich, A. (2005) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2005.02595.x · Cited by 101
“…such as Haemophilus, Escherichia, Neisseria, Citrobacter, Salmonella, Proteus, Klebsiella and Pseudomonas. b-Lactamase (tem-l) has also been demonstrated in isolates from patients infected by these same organisms (Sykes and Matthew 1976) and is widely distributed geographically (Neu 1992).”
BackgroundGandara, A., Mota, L. C., Flores, C. M., Perez, H. R., Green, C. F., & Gibbs, S. G. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9585 · Cited by 101
Siderotyping A Powerful Tool for the Characterization of Pyoverdines
Fuchs, R., Schäfer, M., Geoffroy, V., & Meyer, J. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013395542 · Cited by 101
The Role of Hydrophobic Substituents in the Biological Activityof Glycopeptide Antibiotics
Kerns, R. J., Dong, S. D., Fukuzawa, S., Carbeck, J. D., Kohler, J., Silver, L. L., & Kahne, D. E. (2000) · Journal of the American Chemical Society · doi:10.1021/ja0027665 · Cited by 101
Antimicrobial Activities of Mefloquine and a Series of Related Compounds
Kunin, C. M., & Ellis, W. Y. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.848-852.2000 · Cited by 100
“The antimicrobial era has reached the point where the emergence of resistant microbes is accelerating while the pace of discovery of new drugs is decelerating (11).”
BackgroundTotal Syntheses of (±)-Platencin and (−)-Platencin
Nicolaou, K. C., Tria, G. S., Edmonds, D. J., & Kar, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja906801g · Cited by 100
Engineering Antimicrobial Peptides with Improved Antimicrobial and Hemolytic Activities
Zhao, J. W., Zhao, C., Liang, G., Zhang, M., & Zheng, J. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400477e · Cited by 98
Greenstein, G. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.050140 · Cited by 100
Modugno, E. D., Erbetti, I., Ferrari, L., Galassi, G., Hammond, S. M., & Xerri, L. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.10.2362 · Cited by 100
“The dissemination of existing 13-lactamases and the evolution of new enzymes with extended substrate profiles (2, 5, 6, 14, 15) are a continuing threat to this preeminence (12).”
BackgroundElmberg, J., Berg, C., Lerner, H., Waldenström, J., & Hessel, R. (2017) · Infection Ecology & Epidemiology · doi:10.1080/20008686.2017.1300450 · Cited by 99
“[138,139] It is generally acknowledged that antibiotic resistance is a rapidly emerging threat to human health, causing millions of deaths every year as a”
BackgroundBasu, A., Heitz, K., Strømme, M., Welch, K., & Ferraz, N. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.10.085 · Cited by 99
Implications of human activities for (re)emerging infectious diseases, including COVID-19
Nundu, S. S., Calliope, A. S., Simpson, S. V., Arima, H., Ito, H., Nishimura, T., & Yamamoto, T. (2020) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-020-00239-5 · Cited by 113
Loftin, K. A., Henny, C., Adams, C. D., Surampali, R., & Mormile, M. R. (2005) · Environmental Toxicology and Chemistry · doi:10.1897/04-093r.1 · Cited by 99
Bera, S., Zhanel, G. G., & Schweizer, F. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800345u · Cited by 104
The need for antimicrobial resistance surveillance
Felmingham, D. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf807 · Cited by 99
“For example, fluoroquinolone-resistant S. pneumoniae from Hong Kong were found to be clonal by using pulsed-field gel electrophoresis , multilocus-sequence typing and serotyping.”
Antibacterial activity and toxicity of silver – nanosilver versus ionic silver
Kvı́tek, L., Panáček, A., Prucek, R., Soukupová, J., Vanickova, M., Kolar, M., & Zbořil, R. (2011) · Journal of Physics Conference Series · doi:10.1088/1742-6596/304/1/012029 · Cited by 98
Iron oxide magnetic nanoparticles as antimicrobials for therapeutics
de Toledo, L. D. A. S., Rosseto, H. C., & Bruschi, M. L. (2017) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2017.1337793 · Cited by 100
Cost burden of viral respiratory infections: issues for formulary decision makers
Bertino, J. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01063-4 · Cited by 98
National Trends in the Use of Antibiotics by Primary Care Physicians for Adult Patients With Cough
Metlay, J. P., Stafford, R. S., & Singer, D. E. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1813 · Cited by 98
Monitoring of 14 sulfonamide antibiotic residues in marine products using HPLC-PDA and LC-MS/MS
Won, S. Y., Lee, C., Chang, H. S., Kim, S. O., Lee, S. H., & Kim, D. S. (2011) · Food Control · doi:10.1016/j.foodcont.2011.01.005 · Cited by 97
Zhang, S., Wang, Y., Cao, Z., Xu, J. F., Hu, J., Huang, Y., Cui, C., Liu, H., & Wang, H. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.122771 · Cited by 97
Du, X., Zhang, M., Ma, Y., Wang, X., Liu, Y., Huang, H., & Kang, Z. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.12.025 · Cited by 97
Microbial resistance to drug therapy: A review
Cohen, F. L., & Tartasky, D. (1997) · American Journal of Infection Control · doi:10.1016/s0196-6553(97)90054-7 · Cited by 97
Nanofibers Offer Alternative Ways to the Treatment of Skin Infections
Heunis, T. D. J., & Dicks, L. M. T. (2010) · BioMed Research International · doi:10.1155/2010/510682 · Cited by 98
“aeruginosa strains resistant to several antibiotics have also been reported [30].”
BackgroundRapid Direct Method for Monitoring Antibiotics in a Mouse Model of Bacterial Biofilm Infection
Kadurugamuwa, J. L., Sin, L. V., Yu, J., Francis, K. P., Kimura, R. H., Purchio, T. F., & Contag, P. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3130-3137.2003 · Cited by 97
“inhibitor and a surface perturbating agent (18, 30).”
BackgroundMunir, M. U., Ahmed, A., Usman, M., & Salman, S. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s265934 · Cited by 102
Bacteria resistance to antibiotics: recent trends and challenges
Addo, S. T. O. A. K. K. (2011) · Cited by 95
VanX, a bacterial d -alanyl- d -alanine dipeptidase: Resistance, immunity, or survival function?
Lessard, I. A. D., & Walsh, C. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11028 · Cited by 96
(2009) · Cited by 96
Chang, T.-K., Cheng, T.-M., Chu, H., Tan, S.-H., Kuo, J.-C., Hsu, P.-H., Su, C.-Y., Chen, H.-M., Lee, C., & Kuo, T. (2019) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.9b03048 · Cited by 96
Pata, S., Yaraksa, N., Daduang, S., Temsiripong, Y., Svasti, J., Araki, T., & Thammasirirak, S. (2010) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2010.12.011 · Cited by 95
A microfluidics approach towards high-throughput pathogen removal from blood using margination
Hou, H. W., Gan, H. Y., Bhagat, A. A. S., Li, L. D., Lim, C. T., & Han, J. (2012) · Biomicrofluidics · doi:10.1063/1.4710992 · Cited by 94
Belaissa, Y., Nibou, D., Assadi, A. A., Bellal, B., & Trari, M. (2016) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2016.09.002 · Cited by 95
Gill, J. M., Fleischut, P. M., Haas, S., Pellini, B., Crawford, A. G., & Nash, D. B. (2006) · PubMed · Cited by 94
Antimicrobial resistance in bacteria from horses: Epidemiology of antimicrobial resistance
Maddox, T. W., Clegg, P., Williams, N. J., & Pinchbeck, G. L. (2015) · Equine Veterinary Journal · doi:10.1111/evj.12471 · Cited by 94
“There are 4 primary targets for antimicrobial action; disruption of cell wall synthesis, inhibition of DNA/RNA synthesis, inhibition of protein biosynthesis or interference with a crucial metabolic pathway [4].”
BackgroundZinc-induced antibiotic resistance in activated sludge bioreactors
Peltier, E. F., Vincent, J., Finn, C., & Graham, D. W. (2010) · Water Research · doi:10.1016/j.watres.2010.04.041 · Cited by 94
“Introduction typhimurium, Streptococcus pneumoniae and Staphylococcus Bacterial resistance to currently available antibiotics poses a significant obstacle to the effective treatment and prevention of disease (Davies, 2007; Mølbak, 2004; Neu, 1992; Witte, 1998).”
BackgroundBallard, T. E., Richards, J. J., Wolfe, A. L., & Melander, C. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200801419 · Cited by 94
Prevalence and Antimicrobial Resistance of Foodborne Pathogens Isolated from Food Products in China
Chao, G., Zhou, X., Jiao, X., Qian, X., & Xu, L. (2007) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2007.0088 · Cited by 94
“Antimicrobial resistance of foodborne pathogens was mostly caused by routine use of veterinary medicine to farm animals as growth promotants (Neu, 1992; Tollefson and Miller, 2000).”
Varon, E., Lévy, C., ROCQUE, F. D. L., BOUCHERAT, M., Deforche, D., Podglajen, I., NAVEL, M., & Cohen, R. (2000) · Clinical Infectious Diseases · doi:10.1086/313981 · Cited by 94
“This is generally attributed to extensive use of antibiotics and the selection pressure they exert on bacterial strains of nasopharyngeal flora [2, 3].”
BackgroundOkla, M. K., Alatar, A. A., Al-amri, S. S., Soufan, W. H., Ahmad, A., & Abdel-Maksoud, M. A. (2021) · Plants · doi:10.3390/plants10020252 · Cited by 93
Casteels, P., Romagnolo, J., Castle, M., Casteels-Josson, K., Erdjument‐Bromage, H., & Tempst, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47165-7 · Cited by 93
Tuerk, J., Reinders, M., Dreyer, D., Kiffmeyer, T., Schmidt, K. G., & Kuß, H. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.11.030 · Cited by 93
Antimicrobial Resistance in Bacterial Chronic Sinusitis
Hsu, J., Lanza, D. C., & Kennedy, D. W. (1998) · American Journal of Rhinology · doi:10.2500/105065898781390055 · Cited by 93
Mölstad, S. (1999) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655499750006263 · Cited by 93
Antibiotic resistance amongst healthcare-associated pathogens in China
Yezli, S., & Han, L. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.07.009 · Cited by 92
“Widespread use and misuse of antibiotics worldwide has led to the emergence of drug-resistant bacteria [11, 12] coupled with increased risk of side effects and increased treatment costs [13] .”
BackgroundSchlüsener, M. P., & Bester, K. (2005) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2189 · Cited by 92
Chiesa, L. M., Nobile, M., Panseri, S., & Arioli, F. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.04.184 · Cited by 91
“It is well-established 35 that multiantibiotic-resistant microorganisms results from chromosomal mutations or the exchange of 36 mobile genetic elements, such as plasmids and transposons (Neu, 1992).”
BackgroundActivated carbon nanoparticles from biowaste as new generation antimicrobial agents: A review
Lakshmi, S. D., Avti, P., & Hegde, G. (2018) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2018.08.001 · Cited by 91
Biopolymer K-carrageenan wrapped ZnO nanoparticles as drug delivery vehicles for anti MRSA therapy
Vijayakumar, S., Saravanakumar, K., Malaikozhundan, B., Divya, M., Vaseeharan, B., Durán‐Lara, E. F., & Wang, M. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.12.030 · Cited by 91
An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence
Morin, C. D., Déziel, É., Gauthier, J., Lévesque, R. C., & Lau, G. W. (2021) · Virulence · doi:10.1080/21505594.2021.1926408 · Cited by 93
Yanagisawa, T., Lee, J. T., Wu, H. C., & Kawakami, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51082-1 · Cited by 91
Antibiotic Deactivation by a Dizinc β-Lactamase: Mechanistic Insights from QM/MM and DFT Studies
Xu, D., Guo, H., & Cui, Q. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072532m · Cited by 91
Hegde, S. S., & Shrader, T. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008591200 · Cited by 91
Cheung, A. I., Projan, S. J., Edelstein, R. E., & Fischetti, V. A. (1995) · Infection and Immunity · doi:10.1128/iai.63.5.1914-1920.1995 · Cited by 91
“Although the use of newer antimicrobial agents has been able to control some of these infections, the recent emergence of increased resistance to antistaphylococcal antibiotics (including fluoroquinolones) has made many currently available antibiotics ineffective and is already posing important public health problems…”
BackgroundSharaha, U., Rodriguez‐Diaz, E., Riesenberg, K., Bigio, I. J., Huleihel, M., & Salman, A. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01025 · Cited by 91
Send more data: a systematic review of mathematical models of antimicrobial resistance
Birkegård, A. C., Halasa, T., Toft, N., Folkesson, A., & Græsbøll, K. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0406-1 · Cited by 90
UV-Assisted Deposition of Antibacterial Ag–Tannic Acid Nanocomposite Coating
He, X., Gopinath, K., Sathishkumar, G., Guo, L., Zhang, K., Lu, Z., Li, C. M., Kang, E. T., & Xu, L. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c03566 · Cited by 90
Antibiotic preparations contain DNA: a source of drug resistance genes?
Webb, V., & DAVIES, J. E. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2379 · Cited by 90
“This situation has arisen largely because the extensive use of antibiotics has been accompanied by the widespread appearance of drug resistance genes in bacteria (27, 30).”
BackgroundAminoglycoside antibiotic phosphotransferases are also serine protein kinases
Daigle, D. M., McKay, G. A., Thompson, P. R., & Wright, G. D. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80016-7 · Cited by 90
Biological and Biomechanical Effects of Vancomycin and Meropenem in Acrylic Bone Cement
Baleani, M., Persson, C., Zolezzi, C., Andollina, A., Borrelli, A. M., & Tigani, D. S. (2008) · The Journal of Arthroplasty · doi:10.1016/j.arth.2007.10.010 · Cited by 90
“However, the increasing prevalence of drug-resistant bacteria limits the continued effectiveness of some antibiotic-loaded cements containing aminoglycosides [3,4], and this has stimulated interest in the incorporation of new combinations of antibiotics [6,9,19].”
BackgroundLi, Y., Zhen, J.-B., Tian, Q. C., Shen, C., Zhang, L., Yang, K., & Shang, L. (2020) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.02.084 · Cited by 89
Metadata
- Authors
- Neu, H. C.
- Affiliations
- Columbia University (US)
- Corresponding author
- Neu, Harold C.
- Venue
- Science
- Published
- 1992-08-21
- Volume
- 257
- Issue
- 5073
- Pages
- 1064-1073
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1980595924
- Cited by
- 2,834
- References
- 109
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 57 · 2023: 71 · 2022: 91 · 2021: 93 · 2020: 123 · 2019: 100 · 2018: 122 · 2017: 123 · 2016: 105 · 2015: 87 · 2014: 95 · 2013: 109 · 2012: 99
- FWCI
- 46.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- antibiotic resistance, bacterial resistance, plasmids, transposable elements, horizontal gene transfer, Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus, Enterobacteriaceae, Pseudomonas, antibiotic overuse, hygiene, novel antimicrobial agents
- MeSH terms
- Anti-Bacterial Agents, Bacterial Infections, Cross Infection, Drug Resistance, Microbial, Enterobacteriaceae, Haemophilus influenzae, Humans, Staphylococcus, Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review